Your browser doesn't support javascript.
loading
Measuring Opioid Withdrawal in a Phase 3 Study of a New Analgesic, NKTR-181 (Oxycodegol), in Patients with Moderate to Severe Chronic Low Back Pain.
Henningfield, Jack E; Gudin, Jeffrey; Rauck, Richard; Gimbel, Joseph; Tagliaferri, Mary; Doberstein, Stephen K; Di Fonzo, Carlo; Lu, Lin; Katz, Nathaniel; Siddhanti, Suresh; Schnoll, Sidney.
Afiliação
  • Henningfield JE; Pinney Associates, Bethesda, Maryland.
  • Gudin J; Englewood Hospital and Medical Center, Englewood, New Jersey.
  • Rauck R; Carolinas Pain Institute and The Center for Clinical Research, Winston-Salem, North Carolina.
  • Gimbel J; Arizona Research Center, Phoenix, Arizona.
  • Tagliaferri M; Nektar Therapeutics, San Francisco, California.
  • Doberstein SK; Nektar Therapeutics, San Francisco, California.
  • Di Fonzo C; Nektar Therapeutics, San Francisco, California.
  • Lu L; Nektar Therapeutics, San Francisco, California.
  • Katz N; Tufts University School of Medicine, Boston, Massachusetts.
  • Siddhanti S; Analgesic Solutions, Wayland, Massachusetts, USA.
  • Schnoll S; Nektar Therapeutics, San Francisco, California.
Pain Med ; 21(8): 1553-1561, 2020 08 01.
Article em En | MEDLINE | ID: mdl-32150255
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dor Lombar / Morfinanos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dor Lombar / Morfinanos Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article